Analyst stock forecast
REGENXBIO Forecast: $23.73 Analyst Target
Direct answer
REGENXBIO's average price target is $23.73.
The target implies +217.6% from the recorded current price, and the consensus rating is Buy.
The low target implies +33.9%, the high target implies +569.3%, and the range spans 535.5% of the current price.
Forecast evidence checked September 28, 2026.
Get free REGENXBIO email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $7.47
- Average price target
- $23.73
- High price target
- $50.00
- Low price target
- $10.00
- Low target gap
- +33.9%
- Target upside
- +217.6%
- High target gap
- +569.3%
- Target range width
- 535.5%
- Consensus rating
- Buy
- Analysts
- 11
- Evidence date
- September 28, 2026
- Valid through
- October 5, 2026
Explore related company data
Read the frequently asked questions.
What is REGENXBIO's average price target?
REGENXBIO's verified average price target is $23.73. The target range is $10.00 to $50.00.
How far are REGENXBIO's low and high targets from the recorded price?
The low target implies +33.9%, while the high target implies +569.3%.
How many analysts are included in REGENXBIO's consensus?
The verified consensus includes 11 analysts.
How is REGENXBIO's target upside or downside calculated?
The average target of $23.73 is divided by the recorded price of $7.47, then one is subtracted to produce +217.6%. This does not guarantee a future return.
When was REGENXBIO's analyst forecast verified?
The data was verified on 2026-09-28. The dataset is valid through 2026-10-05.